🔥 TrendingUpdated 7 July 2026 at 14:09

Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles - Investor's Business Daily

Crinetics stock nearly doubled Tuesday after Vertex pledged $10 billion to buy the endocrinology-focused biotech.

Investor's Business Daily·7 July 2026 at 14:09·1 min read
Why It's Trending

Crinetics stock nearly doubled Tuesday after Vertex pledged $10 billion to buy the endocrinology-focused biotech.

GLOBAL — Crinetics stock nearly doubled Tuesday after Vertex pledged $10 billion to buy the endocrinology-focused biotech.

Image source: Investor's Business Daily

Source
Investor's Business Daily
Category
business
Published
7 July 2026 at 14:09
Source Attribution

This report draws on reporting from Investor's Business Daily. DOCFLiX Desk has verified and adapted this report with additional context for our readers.

Read Original Story ↗
✦ Stay Informed

New Investigations.
Every Month. Free.

Get every new investigation delivered to your inbox — fully source-cited, no paywalls, reader-supported. Join 2,400+ readers already subscribed.